Answers are grounded in this paper and cite their sources.
The gamma-ray shielding performance of InxAl1–xAs with different In mole fractions was systematically investigated via the Phy-X/PSD. Key shielding parameters including mass attenuation coefficient (MAC), linear attenuation coefficient (LAC), half-value layer (HVL), tenth-value layer (TVL), mean free path (MFP), atomic cross-section (ACS), electronic cross-section (ECS), effective atomic number (Zeff), effective electron density (Neff), effective conductivity (Ceff), R-value, and equivalent atomic number (Zeq) were calculated over the energy range of 0.015–15 MeV. The results demonstrate that the MAC, LAC, ACS, ECS, Zeff, Ceff, and Zeq values increase with a rising In mole fraction, with In0.8Al0.2As exhibiting the highest values among the studied samples, alongside lower HVL, TVL, and MFP values. At equivalent photon energies, a linear correlation was observed between HVL, TVL, and MFP and the In mole fraction as x increased from 0.25 to 0.8. To quantify the composition-driven enhancement, a comprehensive shielding performance index (ICSP) was defined, and In0.8Al0.2As showed up to a 369% improvement at 0.1 MeV relative to In0.25Al0.75As.These findings suggest that increasing In content effectively enhances the gamma-ray attenuation capability of InAlAs materials. Furthermore, the observed linear relationships between shielding parameters and composition enable the prediction and optimization of shielding performance through compositional tuning, providing a theoretical foundation for the compositional design of III–V compound semiconductors in radiation shielding applications.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: